ABEONA THERAPEUTICS INC. Proceeds from Issuance of Warrants
ABEONA THERAPEUTICS INC. (ABEO) reported Proceeds from Issuance of Warrants of $80.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-03-17
- ABEONA THERAPEUTICS INC. proceeds from issuance of warrants for the quarter ending 2025-12-31 was $0.00.
- ABEONA THERAPEUTICS INC. proceeds from issuance of warrants for fiscal 2025 was $80.00K, a 63.64% decline from fiscal 2024.
- ABEONA THERAPEUTICS INC. proceeds from issuance of warrants for fiscal 2024 was $220.00K.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $80.00K 10-K · filed 2026-03-17 | |
| 2025-09-30 | $80.00K 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | $220.00K 10-K · filed 2026-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |